607 related articles for article (PubMed ID: 28696253)
1. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
[TBL] [Abstract][Full Text] [Related]
2. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.
Kasagi S; Kawano S; Okazaki T; Honjo T; Morinobu A; Hatachi S; Shimatani K; Tanaka Y; Minato N; Kumagai S
J Immunol; 2010 Mar; 184(5):2337-47. PubMed ID: 20139271
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
4. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
5. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
6. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
[TBL] [Abstract][Full Text] [Related]
8. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
Laurent L; Le Fur A; Bloas RL; Néel M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F
Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301
[TBL] [Abstract][Full Text] [Related]
9. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.
Jang E; Jeong M; Kim S; Jang K; Kang BK; Lee DY; Bae SC; Kim KS; Youn J
Cell Transplant; 2016; 25(1):1-15. PubMed ID: 25975931
[TBL] [Abstract][Full Text] [Related]
10. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.
Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM
Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
Ando DG; Sercarz EE; Hahn BH
J Immunol; 1987 May; 138(10):3185-90. PubMed ID: 2952711
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
McMurray RW; Elbourne KB; Lagoo A; Lal S
J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
16. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
17. NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.
Brightbill HD; Suto E; Blaquiere N; Ramamoorthi N; Sujatha-Bhaskar S; Gogol EB; Castanedo GM; Jackson BT; Kwon YC; Haller S; Lesch J; Bents K; Everett C; Kohli PB; Linge S; Christian L; Barrett K; Jaochico A; Berezhkovskiy LM; Fan PW; Modrusan Z; Veliz K; Townsend MJ; DeVoss J; Johnson AR; Godemann R; Lee WP; Austin CD; McKenzie BS; Hackney JA; Crawford JJ; Staben ST; Alaoui Ismaili MH; Wu LC; Ghilardi N
Nat Commun; 2018 Jan; 9(1):179. PubMed ID: 29330524
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.
Kinoshita K; Yoo BS; Nozaki Y; Sugiyama M; Ikoma S; Ohno M; Funauchi M; Kanamaru A
J Immunol; 2003 Jun; 170(11):5793-8. PubMed ID: 12759464
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
Youd M; Blickarz C; Woodworth L; Touzjian T; Edling A; Tedstone J; Ruzek M; Tubo R; Kaplan J; Lodie T
Clin Exp Immunol; 2010 Jul; 161(1):176-86. PubMed ID: 20456409
[TBL] [Abstract][Full Text] [Related]
20. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
